Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT05121922 |
Other study ID # |
IL001 |
Secondary ID |
|
Status |
Recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
August 15, 2021 |
Est. completion date |
June 30, 2025 |
Study information
Verified date |
November 2022 |
Source |
University of Oslo |
Contact |
Ingunn Leeber, MD |
Phone |
+47 936 10 535 |
Email |
ingunnleeber[@]gmail.com |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This is a study on Metacognitive therapy in general practice in Norway. The intervention is a
small pilot study to examine whether Metacognitive therapy is feasible in an ordinary general
practice. Will the physicians be capable to learn and provide the therapy method for their
patients with MUPS and is is possible to implement this in an ordinary general practice
routine? Both physicians and their patients will be asked to respond to a questionnaire on
perceived utility of the treatment.
Description:
Metacognitive therapy is different from Cognitive therapy in the sense that it adresses the
individual's attention towards potential worries and threats and also the management
performed by the patient to avoid these. Also the individual's capacity to produce
empowerment to manage these threats are of interest in the talks with the health care
provider. - In this study, General Practitioners with specific training in Metacognitive
therapy will be asked to recruit 2-3 patients with Medically Unexplained Physical Symptoms
each and invite them to a series of Metacognitive Therapy. The patients and physicians will
then provide their assessments of the treatment on a number of questionnaires. To explore the
Sense of coherence and Empowerment among patients with Medically Unexplained Symptoms, the
physicians will be asked to recruit six patients each to respond to a questionnaire.